Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic B7-H3 CAR-γδT Cell Therapy Recurrent/Progressive High Grade Glioma（R/R HGG）

NCT06018363 is registered in ClinicalTrials.gov with Dushu Lake Hospital Affiliated to Soochow University as lead sponsor.

NCT NCT06018363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06018363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic B7-H3 CAR-γδT Cell Therapy Recurrent/Progressive High Grade Glioma（R/R HGG）
Lead sponsor
Dushu Lake Hospital Affiliated to Soochow University
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 1, 2023
Completion date
December 31, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain gliomas, gbm, high-grade gliomas